AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
At Least 400 Vaccine Products Are In The Works.(Brief Article)
2001 APR 11 - (NewsRx.com & NewsRx.net) --
Despite recent reports of the potential dangers associated with certain pediatric vaccines, controversies surrounding clinical trial procedures, and conflicting patent positions, the pipeline for vaccine products is more robust than ever.
According to a new study from Theta Reports, New York, more than 15 new immunotherapy medicines have come to market in the past two years and at least 25 products are in late stage clinical trials. Furthermore, at least 400 vaccine products are in various earlier stages of development.
Therapeutic vaccines, the category that represents the vast majority of early-stage products, include antibody, gene, and immunoprotein medicines. According to the study, "Vaccines 2001: The world markets," the therapeutic vaccine segment alone generated product sales of $2 billion in 1999 and is expected to show annual average growth of 21% to reach $4.5 billion in 2005.
The road will not be without bumps, though. Recent recalls of vaccines - such as AHP/Wyeth's RotaShield rotavirus vaccine - and consumer wariness have prompted the U.S. Food and Drug Administration (FDA) to reassess the clinical trial process for vaccines. However, the setbacks appear not to have deterred companies with high hopes ...
- FTC clears reacquisition of intranasal influenza vaccine products.
- Newspaper article from: Vaccine Weekly June 23, 2004 700+ words
...immunization of individuals less than 5 years of age, or 50 years of age and older. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- MedImmune reacquires rights to nasal flu vaccine products, including FluMist.
- Newspaper article from: Vaccine Weekly May 26, 2004 700+ words
...events, and royalties on future product sales. Additional terms were not disclosed. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- CHINA TO IMPOSE COMPULSORY BATCH INSPECTION ON VACCINE PRODUCTS.
- News wire article from: AsiaPulse News August 29, 2005 700+ words
...group meningococcal polysaccharose vaccine products starting from October 1 this year...administration will be carried out on all vaccine products for preventive purpose, said the...batch-by-batch examination on the vaccine products means these products are administered...
- Flood of Vaccine Products Headed for Growing Market Despite Obstacles.
- Press release article from: PR Newswire March 21, 2001 700+ words
...procedures, and conflicting patent positions, the pipeline for vaccine products is more robust than ever. According to a new study from...late stage clinical trials. Furthermore, at least 400 vaccine products are in various earlier stages of development. Therapeutic...
- Nabi Biopharmaceuticals Begins Internal Expansion of its Manufacturing Capacity...
- Press release article from: PR Newswire July 12, 2004 700+ words
...well as its next generation of Gram-positive pipeline vaccine products. These vaccines are all based on the company's conjugate...during its 15-year history. "Nabi Biopharmaceuticals' vaccine products under development will address some of the world's most...
- U.S. International Trade Commission Initiates Investigation Against Acambis plc...
- Press release article from: PR Newswire Europe September 21, 2005 700+ words
...an investigation of patent infringement on MVA smallpox vaccine products marketed by Acambis plc. The investigation is based on...bidding process to supply millions of doses of MVA smallpox vaccine products to the U.S. Department of Health and Human Services...
- Eradiction Programmes and New Higher Value Vaccine Products to Provide Growth...
- Press release article from: PR Newswire March 11, 1997 700+ words
...by the UK (18.3 per cent) and Iberia (12.7 per cent) introduction of new higher value, genetically engineered vaccine products and an anticipated easing of regulations concerning the development of products derived from biotechnology have been identified...
- New Data Showing First Drop in 20 Years, Provides Cautious Hope That Vaccine...
- Press release article from: PR Newswire April 22, 2004 700+ words
...Act of 2004," was recently introduced by Rep. Dave Weldon, M.D., (R-FL), which would remove mercury from all vaccine products. SafeMinds is leading a national grassroots effort to gain support and passage of this bill. CONTACT: Joe Giganti for...
Source: HighBeam Research, At Least 400 Vaccine Products Are In The Works.(Brief Article)